Lexeo Therapeutics’ Post

Curious about the trends shaping CVL's partnerships with top cardiovascular practices? Steven Collins, Chief Development Officer, dives into these trends in the first video in our new series, “Top 10 Considerations When Selling Your Cardiology Practice”. While physician specialty consolidation isn't new, it's gaining traction in cardiology. Now more than ever, more cardiologists are moving away from the umbrella of hospitals to private care. #CardiovascularMedicine #HealthcareTrends #CVL

💜 What an incredible opportunity to get to participate in University of Washington initiative for fostering #learningorganization! 🔅Got to talk about evaluation of cardiac murmurs and #valvularheartdisease using predominantly #echo. ❗️Key take-home points: ✅ Not all murmurs are bad. Diastolic ones are always pathological. ✅ Chronic valve disease can go unnoticed for years! Human body is amazing at conditioning itself and tolerating chronic regurgitation (stenosis too, though, less so). ✅ Echocardiographic monitoring and symptoms assessment are the mainstay of clinical evaluation for determining optimal timing for valvular intervention. ✅ Secondary mitral regurgitation is particularly challenging. It is critical to ensure we max out medical management of #heartfailure prior to referring for possible surgical or transcatheter intervention. ✅ People with prosthetic heart valves undergoing dental procedures with manipulation of gingival or periapical tissue should get antibiotic prophylaxis for infective endocarditis. 🪯 Can’t wait for next year’s meeting! #cardiology #medicine #education #learning John Michael Maier Pat Lara Michelle Rastelli, MHA, RDCS MedAxiom - An ACC Company Mpirik (Acquired by Tempus AI) Tempus AI Aidoc Vantari VR American College of Cardiology American Society of Echocardiography American Heart Association University of Alabama at Birmingham Harvard University American Medical Women's Association (AMWA) Women As One The Journal Of Heart Valve Disease Edwards Surgical Structural Heart Therapies

In this video interview, SCAI experts discuss the key highlights of the article "Effect of Race on Clinical Outcomes Following Hemodynamically Supported High-Risk Percutaneous Coronary Intervention," published in JSCAI. Watch now 🎥 https://lnkd.in/eXJcQpvU #PCI #InterventionalCardiology

Don't miss the up-coming Cardiology Coffee Break...Interesting Topic about ECG workflow; You will find the link below on how to register. #cardiology #ECG #digitalworkflows

Interesting case presented by Prof. Haim Danenberg, head of interventional cardiology at the Wolfson Medical Center in Holon, Israel: "48 y-o admitted for a STEMI- treated with PCI - EluNIR-PERL DES to ostial LAD. 3 weeks after - PCI to ostial LCX. The markers on the EluNIR-PERL allow for precise deployment without risking the LM. An additional EluNIR-PERL in the mid LAD without touching Diagonal". This case highlights the importance of precision in interventional cardiology and the valuable role of the markers on the EluNIR-PERL in enhancing patient outcomes. #Innovation #EluNIRPERL #PatientOutcomes #HealthTech #cardiovascular #coronary

CHEERS for Ashish Gupta, MD, PhD and study coordinator Kathleen Oates of the Guardian Research Organization, FLORIDA CARDIOLOGY GROUP P.A. in Winter Park, FL on the 1st enrollment in the DEEPER REVEAL (NCT05358353) trial. Many thanks to Dr. Gupta, Kathleen, Julia Risk, Emily Ripley, Kasidee Graham, Farah Bhatti and Reflow's Shaun Dauzat, BSRT(R), MBA, ACRP-CP. The patient was successfully treated for a 140mm lesion in the anterior tibial artery. The clinical trial is designed to evaluate the safety and efficacy of the Bare Temporary Spur Stent System (investigational use only). https://lnkd.in/gnJE2X4K #clinicaltrials #clinicaltrial #interventionalcardiology #medicaldevices #clifighters #peripheralarterydisease #angiography #criticallimbischemia

Understand the Effect of Race on Clinical Outcomes Following Hemodynamically Supported High-Risk Percutaneous Coronary Intervention as SCAI experts discuss the JSCAI published article in this video interview. Watch now 🎥 https://lnkd.in/gMZsMQ3U #PCI #InterventionalCardiology

Healthcare practitioners, please join Decker Weiss, NMD, in this free webinar on Clinical Perspectives in Cardiology! It's Feb 15, 2024, 8:00 PM EST. Dr. Decker Weiss will share his clinical experiences with cardiovascular issues. He’ll share how functional medicine can be supportive of conventional approaches. Register in the link here: https://lnkd.in/e9j8R3rJ #functionalmedicine #naturopathicmedicine #cardiovascular

Dive into the future of cardiology with MedAxiom and American College of Cardiology! 🚀 Join the conversation as we explore the evolving landscape of cardiovascular care, from value-based approaches to navigating the impact of private equity. 💡 Tune in to the ACCEL audio interview featuring Jerry Blackwell, MD, MBA, FACC, and Joseph Marine, MD, MBA, FACC, for insights on shaping the future of patient-centric healthcare: https://hubs.li/Q02tRZ8D0 #CardiologyFuture #ValueBasedCare #HealthcareInnovation

I'm thrilled to share that I've successfully finished the 12-week Pharmacotherapy Module 1 course, specializing in Cardiology and Respiratory Disease! 🌟 This journey has enhanced my comprehension of pivotal healthcare domains, providing me with advanced expertise to better care for patients dealing with cardiovascular and respiratory conditions. A heartfelt thanks to CliMed Research Solutions Research Solutions and Dr. Ajit Singh for this invaluable opportunity, making this experience both enriching and fulfilling. I eagerly anticipate applying these newfound insights in my professional journey and advancing further in the field of pharmacotherapy. #pharmacotherapy #cardiology #respiratory medicine